Engineered Anthrax Lethal Toxin For Targeted Delivery Read more about Engineered Anthrax Lethal Toxin For Targeted Delivery Australia2013305744Filed on 2013-08-22
Use Of P47 From Plasmodium Falciparum (PFS47) Or Plasmodium Vivax (PVS47) As A Vaccine Or Drug Screening Targets For The Inhibition of Human Malaria Transmission Read more about Use Of P47 From Plasmodium Falciparum (PFS47) Or Plasmodium Vivax (PVS47) As A Vaccine Or Drug Screening Targets For The Inhibition of Human Malaria Transmission US Application 14/421,964Filed on 2015-02-16
Use Of P47 From Plasmodium Falciparum (Pfs47) Or Plasmodium Vivax (PVS47) As A Vaccine Or Drug Screening Targets For The Inhibition of Human Malaria Transmission Read more about Use Of P47 From Plasmodium Falciparum (Pfs47) Or Plasmodium Vivax (PVS47) As A Vaccine Or Drug Screening Targets For The Inhibition of Human Malaria Transmission India416/KOLNP/2015Filed on 2013-08-16
Use Of P47 From Plasmodium Falciparum (PfS47) Or Plasmodium Vivax (PVS47) As A Vaccine Or Drug Screening Targets For The Inhibition of Human Malaria Transmission Read more about Use Of P47 From Plasmodium Falciparum (PfS47) Or Plasmodium Vivax (PVS47) As A Vaccine Or Drug Screening Targets For The Inhibition of Human Malaria Transmission European Patent13830027.2Filed on 2013-08-16
Use Of P47 From Plasmodium Falciparum (PFS47) Or A Plasmodium Vivax (PVS47) As A Vaccine Or Drug Screening Targets For The Inhibition of Human Malaria Transmission Read more about Use Of P47 From Plasmodium Falciparum (PFS47) Or A Plasmodium Vivax (PVS47) As A Vaccine Or Drug Screening Targets For The Inhibition of Human Malaria Transmission China201380054025.3Filed on 2015-04-16
Use Of P47 From Plasmodium Falciparum (PFS47) Or A Plasmodium Vivax (PVS47) As A Vaccine Or Drug Screening Targets For The Inhibition of Human Malaria Transmission Read more about Use Of P47 From Plasmodium Falciparum (PFS47) Or A Plasmodium Vivax (PVS47) As A Vaccine Or Drug Screening Targets For The Inhibition of Human Malaria Transmission BrazilBR112015003184-6Filed on 2015-02-12
INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS Read more about INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS Canada2879182Filed on 2005-05-20
LEISHMANIA VACCINE USING SAND FLY SALIVARY IMMUNOGEN Read more about LEISHMANIA VACCINE USING SAND FLY SALIVARY IMMUNOGEN MexicoMX/a/2010/012069Filed on 2009-05-06
METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NKT CELLS Read more about METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NKT CELLS Japan2012-186893Filed on 2002-06-14
Methods for Using Extracellular Adenosine Inhibitors and Adenosine Receptor Inhibitors to Enhance Immune Response and Inflammation Read more about Methods for Using Extracellular Adenosine Inhibitors and Adenosine Receptor Inhibitors to Enhance Immune Response and Inflammation Denmark02804693.6Filed on 2002-11-14